CSII

Cardiovascular Systems, Inc. (CSII) | Rumor.io

Cardiovascular Systems

CSII

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about CSII?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Apr 27

Cardiovascular Systems, Inc. ($CSII) has been acquired by Abbott Laboratories, with the merger completing on April 27, 2023.
Several high-ranking executives, including the Chairman, Officers, and Directors, have sold significant amounts of $CSII stock on April 27, 2023.
$CSII has been initiated at a "hold" rating by StockNews.com.

Generated by AI

Sentiment

Of the messages about CSII that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100%
Bearish	—	—	—	0%

Bullish· Feb 9

Cardiovascular Systems, Inc. ($CSII) is being acquired by $ABT for $20 per share, with a total deal value of approximately $890 million.
Analysts are mildly confident in $CSII, with a 73% buy consensus based on 14 analysts' opinions.
$CSII is expected to show strong growth in revenue over the next 5 years, with a 48.01% price increase since the initial alert.

Bearish· Oct 25

Cardiovascular Systems, Inc. missed revenue expectations despite beating EPS estimates by $0.01.
The company reported a loss of $0.06 per share, in line with consensus estimates.
Cardiovascular Systems, Inc. reported first-quarter earnings that missed revenue estimates at $49.68 million.

Generated by AI

Topics

Of the messages about CSII that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Earnings· Jul 30

Cardiovascular Systems, Inc. ($CSII) beats earnings per share (EPS) estimates by $0.05.
$CSII slightly beats revenue expectations.
$CSII reports FQ4 earnings of 11c EPS and $59.15M in revenue.

Analysts· Oct 8

Needham downgraded CSII to Buy with a target price of $18.00.
Bank of America downgraded CSII to Underperform.
The median target price for CSII is $17.5, based on 4 analyst ratings in the last 7 days.

Announcements· Feb 9

Abbott has agreed to acquire Cardiovascular Systems, Inc. for $20 per share, or approximately $890 million.
The acquisition is expected to provide Abbott with complementary technologies to its vascular offering.
Cardiovascular Systems' stock price surged 47% before trading on the news of the acquisition.

Generated by AI

Community

Of the messages about CSII, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Feb 8

Abbott is acquiring Cardiovascular Systems, Inc. for $20 per share or $890M in a definitive agreement.
Cardiovascular Systems reported a loss of $0.20 EPS and $61.45M in revenues for FQ2 earnings, missing the Estimize Consensus by 3c and $1.66M in revenue.
Cardiovascular Systems' fiscal 2023 second quarter revenues were $61.5 million, representing an increase of $2.3 million or 3.9% compared to the second quarter last year.

Newcomers· Feb 10

Analysts are setting a high target price for Cardiovascular Systems, Inc. ($CSII) stock, suggesting a strong potential for growth.
Shareholders are being alerted to potential buyout or merger discussions involving Cardiovascular Systems, Inc. ($CSII), which may impact stock value.
A large block trade of $CSII stock has been reported, with 109,450 shares traded at $19.72, resulting in a significant amount of $2.16 million.

Generated by AI

News

UK weather: Why heatwaves hit women harder

Experts are calling for better awareness of the heat-related risks to women and more targeted efforts to protect them.

2mo agoBBC

Also Discussed

Investors talking about CSII also mention

#	Name	Attention
1	ABMD - Abiomed, Inc.	——
2	Edwards Lifesciences CorporationEW	0%new
3	Koninklijke Philips N.V. ADRPHG	0%0
4	Abbott LaboratoriesABT	0%-0.03
5	NAVB - Navidea Biopharmaceuticals, Inc.	——
6	RCII - Rent-A-Center, Inc.	——
7	ICU Medical, Inc.ICUI	0%0
8	LHCG - LHC Group, Inc.	——
9	UIHC - United Insurance Holdings Corp.	——
10	CONMED CorporationCNMD	0%new